Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-QUAD: HIV Post-Exposure Prophylaxis Pilot
NCT00949234Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Mar 2010
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University of California, Los Angeles. Started Mar 2010; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00949234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00949234.